top of page


Multigene Panel Genetic Testing for Breast Cancer: Beyond BRCA — Who Should Be Tested?
Besides BRCA1 and BRCA2, other genes such as PALB2, TP53, CHEK2 and ATM raise breast cancer risk. Multigene panel testing guides treatment, screening and family prevention. Testing criteria under ASCO–SSO and NCCN, result types, and what to know before testing.
ป้าหมอนุช


Oncotype DX and MammaPrint Tumor Genomic Tests: Deciding Whether Chemotherapy Is Needed
Tumor genomic tests help many women with HR+/HER2− breast cancer avoid unnecessary chemotherapy. Who should be tested, how to read the Recurrence Score, and what the TAILORx, RxPONDER and MINDACT trials showed.
ป้าหมอนุช


BRCA Genes and Family History: Understanding Inherited Breast Cancer Risk
BRCA1 and BRCA2 are genes involved in DNA repair. When a person has a harmful change, often called a pathogenic or likely pathogenic variant, in one of these genes, the risk of breast cancer, ovarian cancer, and certain other cancers may increase significantly. People whose family history suggests inherited cancer risk should speak with a doctor or genetic counselor before deciding whether genetic testing is appropriate. This article explains what BRCA genes are, who may cons
Youwanush Kongdan
bottom of page

